Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Neutrophil-Derived Myeloperoxidase Aggravates Non-Alcoholic Steatohepatitis in Low-Density Lipoprotein Receptor-Deficient Mice

  • Sander S. Rensen ,

    s.rensen@maastrichtuniversity.nl

    Affiliation Department of Surgery, NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Centre, Maastricht, The Netherlands

    ⨯
  • Veerle Bieghs,

    Affiliation Department of Genetics and Cell Biology, NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Centre, Maastricht, The Netherlands

    ⨯
  • Sofia Xanthoulea,

    Affiliation Department of Surgery, NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Centre, Maastricht, The Netherlands

    ⨯
  • Evi Arfianti,

    Current address: Department of Medical Biology, Riau University, Pekanbaru, Indonesia

    Affiliation Department of Surgery, NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Centre, Maastricht, The Netherlands

    ⨯
  • Jaap A. Bakker,

    Affiliation Department of Clinical Genetics, NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Centre, Maastricht, The Netherlands

    ⨯
  • Ronit Shiri-Sverdlov,

    Affiliation Department of Genetics and Cell Biology, NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Centre, Maastricht, The Netherlands

    ⨯
  • Marten H. Hofker,

    Affiliation Department of Pathology & Medical Biology, Medical Biology Section, Molecular Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

    ⨯
  • Jan Willem Greve,

    Affiliations Department of Surgery, NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Centre, Maastricht, The Netherlands, Department of Surgery, Atrium Medical Center Parkstad, Heerlen, The Netherlands

    ⨯
  • Wim A. Buurman

    Affiliation Department of Surgery, NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Centre, Maastricht, The Netherlands

    ⨯

Abstract

Background

Chronic inflammation and oxidative stress play fundamental roles in the pathogenesis of non-alcoholic steatohepatitis (NASH). Previously, we reported that myeloperoxidase (MPO), an aggressive oxidant-generating neutrophil enzyme, is associated with NASH severity in man. We now investigated the hypothesis that MPO contributes to the development and progression of NASH.

Methodology

Low-density lipoprotein receptor-deficient mice with an MPO-deficient hematopoietic system (LDLR−/−/MPO−/−tp mice) were generated and compared with LDLR−/−/MPO+/+tp mice after induction of NASH by high-fat feeding.

Results

High-fat feeding caused a ∼4-fold induction of liver MPO in LDLR−/−/MPO+/+ mice which was associated with hepatic sequestration of MPO-positive neutrophils and high levels of nitrotyrosine, a marker of MPO activity. Importantly, LDLR−/−/MPO−/−tp mice displayed markedly reduced hepatic neutrophil and T-lymphocyte infiltration (p<0.05), and strong down regulation of pro-inflammatory genes such as TNF-α and IL-6 (p<0.05, p<0.01) in comparison with LDLR−/−/MPO+/+tp mice. Next to the generalized reduction of inflammation, liver cholesterol accumulation was significantly diminished in LDLR−/−/MPO−/−tp mice (p = 0.01). Moreover, MPO deficiency appeared to attenuate the development of hepatic fibrosis as evident from reduced hydroxyproline levels (p<0.01). Interestingly, visceral adipose tissue inflammation was markedly reduced in LDLR−/−/MPO−/−tp mice, with a complete lack of macrophage crown-like structures. In conclusion, MPO deficiency attenuates the development of NASH and diminishes adipose tissue inflammation in response to a high fat diet, supporting an important role for neutrophils in the pathogenesis of metabolic disease.

Citation: Rensen SS, Bieghs V, Xanthoulea S, Arfianti E, Bakker JA, Shiri-Sverdlov R, et al. (2012) Neutrophil-Derived Myeloperoxidase Aggravates Non-Alcoholic Steatohepatitis in Low-Density Lipoprotein Receptor-Deficient Mice. PLoS ONE 7(12): e52411. https://doi.org/10.1371/journal.pone.0052411

Editor: Yu Wang, The University of Hong Kong, Hong Kong

Received: August 2, 2012; Accepted: November 13, 2012; Published: December 20, 2012

Copyright: © 2012 Rensen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Funding: Supported by the Senter Novem Innovation Oriented Research Program on Genomics, grant IGE05012 (MH/JWG/WB), a Transnational University Limburg grant and a Dutch Digestive Foundation project grant (WO 09-46) to SR, and VENI grant 916.76.070 from the Netherlands Organization for Scientific Research (RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

The progression of non-alcoholic steatohepatitis (NASH) is driven by activation of the innate immune system, which contributes to hepatocyte damage and fibrosis in various ways [1]. Both Kupffer cells and the complement system have been shown to be involved [2], [3]. Furthermore, neutrophil accumulation is a prominent feature of the inflammation observed in NASH [4], [5]. These phagocytes are notorious for their ability to induce tissue damage through generation of aggressive oxidants, which is largely mediated by the myeloperoxidase (MPO) enzyme [6], [7]. Importantly, increased MPO activity has previously been suggested to promote lipid peroxidation in steatotic livers [4], a process involved in the progression of simple steatosis to steatohepatitis. Recently, we obtained additional evidence implicating MPO in the progression of NASH by showing that accumulation of HOCl-modified proteins and nitrated proteins was associated with increased hepatic CXC chemokine expression in the liver of patients with NASH [5]. MPO also catalyzes nitration of protein tyrosyl groups, which is associated with human non-alcoholic fatty liver disease (NAFLD) as well [5], [8].

Next to its ability to induce tissue damage, MPO also directly regulates inflammatory pathways and processes involved in fibrosis. For example, MPO enhances macrophage cytotoxicity [9] and induces neutrophil activation [10]. In addition, MPO-derived HOCl causes fragmentation of the extracellular matrix [11], resulting in activation of hepatic stellate cells.

All in all, there is compelling evidence to suggest that MPO plays a crucial role in the pathogenesis of NASH by affecting inflammation, oxidative stress, and fibrogenesis. We now report on studies with NASH-prone [12] low-density lipoprotein receptor-deficient mice (LDLR−/− mice) transplanted with MPO−/− or MPO+/+ bone marrow. Our data demonstrate that MPO deficiency attenuates hepatic cholesterol accumulation, inflammation, and potentially fibrosis in response to a high-fat diet, indicating an important role for MPO in metabolic liver disease.

Materials and Methods

Ethics Statement

This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Committee for Animal Welfare of Maastricht University (Permit Number: 2007-034). The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996).

Mice

Twelve weeks old female LDLR−/− (Jackson Laboratory, Bar Harbor, Maine) and MPO−/− [13] or MPO+/+ mice, on a C57BL/6J background, were randomly assigned to the LDLR−/−/MPO−/−tp (n = 9) or the LDLR−/−/MPO+/+tp (n = 9) group. LDLR−/− mice were subjected to 11 Gy of radiation. The following day, 107 bone marrow cells of MPO−/− and MPO+/+ mice were injected into the tail vein of recipient LDLR−/− mice. One LDLR−/−/MPO+/+tp mouse did not survive after bone marrow transplantation. After 10 weeks recovery, NASH was induced by feeding the mice a diet containing 17% casein, 0.3% DL-methionine, 34% sucrose, 14.5% cornstarch, 0.2% cholesterol, 5% cellulose, and 21% butter for 8 weeks (Scientific Animal Food and Engineering, Villemoisson-sur-orge, France) [12]. The engraftment efficiency was determined as previously described [14] and found to be 95.2%.To evaluate the effect of the intervention in relation to the diet key parameters assessed in the high-fat fed mice in the current study are compared with those obtained from chow-fed mice in a recently published parallel experiment [15].

Tissue Specimens

Mice were sacrificed by CO2 asphyxation followed by removal of liver and mesenteric adipose tissue. Tissues were divided into pieces and 1) snap-frozen in liquid nitrogen for RT-PCR, ELISA, and lipid analysis, 2) fixed with formalin and embedded in paraffin for histopathology and immunohistochemistry, 3) snap-frozen in 2-methylbutane after embedding in Tissue-Tek OCT (Sakura Finetek, Zoeterwoude, the Netherlands).

Lipid Analysis

Tail vein blood was collected after 4 hours fasting in heparin coated glass capillaries. Plasma and liver triglyceride and cholesterol were measured using the GPO-PAP kit according to the manufacturer’s instructions (Roche, Basel, Switzerland) after lipid extraction was performed using a modified Folch technique [16]. Protein content was measured by the BCA method (Pierce, Rockford, IL).

Histology and Immunohistochemistry

Paraffin-embedded sections were cut and stained with haematoxylin and eosin for histopathological analysis and with Sirius red to study collagen distribution. The degree of steatosis, lobular inflammation, hepatocyte ballooning, and fibrosis was scored semi-quantitatively on a 3-point scale by an experienced animal pathologist. Frozen liver sections were immersed in Oil Red O/isopropanol (Sigma-Aldrich, Zwijndrecht, the Netherlands) to stain neutral lipids. Immunohistochemical staining for MPO, Ly-6G, Mac-1, F4/80, and CD3 was performed as previously described [5], [12], [14]. For quantification, six 200× fields were counted in a blinded fashion by two observers, and cell number was expressed relative to the sectioned area per mm2. MPO foci were defined as aggregation of >2 MPO-positive cells.

Quantitative Real-time PCR

Total RNA isolation, reverse transcription, and real-time PCR was performed as previously described [5], using the primer sets presented in Table 1. Relative gene expression was normalised against cyclophilin A and β-actin gene expression.

thumbnail
Download:
Table 1. Primer sequences for quantitative RT-PCR.

https://doi.org/10.1371/journal.pone.0052411.t001

Nitrotyrosine, Myeloperoxidase, and Alanine Amino Transferase ELISA

Liver samples were homogenized with a mini-bead beater and glass beads in lysis buffer (300 mM NaCl, 30 mM Tris-HCl (pH 7.4), 2 mM MgCl2, 2 mM CaCl2, 1% Triton X-100, in the presence of Pepstatin A, Leupeptin, and Aprotinin (all at 20 ng/ml)). Plasma and liver MPO and liver nitrotyrosine were measured using sandwich ELISA according to the manufacturer’s protocol (Hycult Biotechnology, Uden, the Netherlands). Plasma alanine amino transferase (ALT) was determined by ELISA (Antibodies-online, Aachen, Germany). Samples were analysed in duplicate in the same run. The intra-assay coefficient of variance was <10%.

Hydroxyproline Assay

Hydroxyproline content of proteins was measured after acid hydrolysis with 6M HCl. Amino acid analysis was performed as recently described [17]. Briefly, samples were introduced into a tandem mass spectrometer using UPLC. Amino acids were measured in multiple reaction mode in ESI-positive mode. The mass transition 131.75>85.9 was used for the identification of hydroxyproline. Stable isotope-labelled asparagine was used as internal standard.

Statistics

Data are represented as mean±SEM. Differences between groups were analysed using the Mann Whitney test, or one-way ANOVA with Dunnett’s test for multiple comparison. Statistical analyses were performed using Graphpad Prism 5.02 for Windows (Graphpad Software, San Diego, CA). A p value<0.05 was considered statistically significant.

Results

Hepatic MPO Accumulation in LDLR−/− Mice after High-fat Feeding

Hyperlipidemic mice such as LDLR−/− mice provide an excellent model for the study of NASH since they uniformly exhibit all of its phenotypic aspects, including hepatic inflammation and fibrosis, without requiring non-physiological diets [12], [14], [18]. Moreover, they exhibit insulin resistance [19], enabling mechanistic studies of NASH in the appropriate context of metabolic aberrations as observed in humans. Previously, high-fat feeding of these hyperlipidemic mice was shown to lead to elevated plasma MPO levels [12], [20]. We now assessed whether a three weeks high-fat diet also affected liver MPO, using previously described liver samples [12]. High-fat feeding caused a 3.7-fold increase of liver MPO protein in LDLR-deficient animals (p<0.01; Fig. 1a). This was associated with substantial infiltration of MPO-positive neutrophils into the liver, and not caused by expression of MPO in Kupffer cells (Fig. 1b). These neutrophils frequently assembled into aggregate structures around hepatocytes with macrovesicular steatosis, resembling the crown-like macrophage structures found in adipose tissue of obese animals [21]. Thus, hepatic lipid accumulation triggered by a high-fat diet is associated with liver neutrophil infiltration, leading to increased hepatic MPO protein levels.

thumbnail
Download:
Figure 1. Strong high-fat diet-induced induction of MPO in the liver.

A) Total liver MPO content of LDLR−/− mice as assessed by ELISA was almost four-fold increased by three weeks of high-fat feeding (19±1 vs. 68±10 ng/µg protein, p<0.01; n = 6 in both groups). B) MPO immunostaining reveals infiltration of neutrophils into the liver of LDLR−/− mice after three weeks of high-fat feeding (see arrows; 100× magnification). Many neutrophils are organized into aggregates predominantly surrounding steatotic hepatocytes (right panel; 200× magnification). MPO was not detected in Kupffer cells.

https://doi.org/10.1371/journal.pone.0052411.g001

Reduced MPO Activity in LDLR−/−/MPO−/−tp Mice

The accumulation of MPO in the liver upon high-fat feeding suggested that MPO might contribute to the pathogenesis of NASH. To further examine the role of MPO in NASH, we took advantage of the fact that MPO is exclusively expressed in the hematopoietic system [22], and performed bone marrow transplantation experiments that resulted in the generation of combined MPO-deficient, LDL-R-deficient mice (LDLR−/−/MPO−/−tp) mice. LDLR−/−/MPO+/+tp controls and LDLR−/−/MPO−/−tp mice had a similar body weight, and diet-induced weight gain was comparable (LDLR−/−/MPO+/+tp from 19.9±0.4 to 21.8±0.3 g, LDLR−/−/MPO−/−tp: from 20.0±0.2 to 21.9±0.7 g).

After high-fat feeding, MPO plasma levels in the LDLR−/−/MPO+/+tp mice were 324 ng/ml whereas plasma from LDLR−/−/MPO−/−tp animals contained only 22 ng/ml of MPO (p<0.01; Fig. 2a). Similar to plasma MPO, liver MPO was very significantly reduced in the LDLR−/−/MPO−/−tp group after high-fat feeding as shown by quantification of MPO-positive cell numbers, with levels well under those observed in chow-fed LDLR−/−/MPO+/+ mice(p<0.001; Fig. 2b).

thumbnail
Download:
Figure 2. Reduced hepatic MPO and MPO-derived nitrated proteins in LDLR−/−/MPO−/−tp mice after 8 weeks of high-fat feeding.

A) Plasma MPO levels of LDLR−/−/MPO−/−tp and LDLR−/−/MPO+/+tp mice (22±7 vs. 324±52 ng/ml, p<0.01). B) The MPO-positive cell number is strongly reduced in the liver of LDLR−/−/MPO−/−tp vs. LDLR−/−/MPO+/+tp mice (49.5±7.6 vs. 4.0±1.6 cells/mm2, p<0.01), and much lower than those observed in LDLR−/−/MPO+/+ mice on chow. C) Hepatic levels of nitrotyrosine, a marker of MPO activity, are reduced in LDLR−/−/MPO−/−tp animals in comparison with LDLR−/−/MPO+/+tp mice (126±7 vs. 149±9 mmol/µg protein, p = 0.02).

https://doi.org/10.1371/journal.pone.0052411.g002

To investigate if the marked reduction of hepatic MPO in LDLR−/−/MPO−/−tp mice translated into diminished generation of MPO-mediated cytotoxic products, we studied hepatic levels of nitrotyrosine, a protein modification generated at sites of inflammation as a result of the activity of several enzymes among which MPO, which accumulates in NAFLD [5], [8], [23]. As expected, mice in the LDLR−/−/MPO−/−tp group displayed significantly reduced levels of nitrotyrosine in the liver, consistent with reduced MPO activity (Fig. 2c; p<0.05).

Characterization of NASH Severity

Histological examination of the livers after H/E-staining revealed diffuse microvesicular and macrovesicular steatosis in both groups (Fig. 3). Semi-quantitative evaluation of the extent of steatosis showed no statistically significant differences between LDLR−/−/MPO+/+tp and LDLR−/−/MPO−/−tp mice (2.4±0.3 vs. 2.1±0.2, p = 0.43). Inflammatory cell foci were observed in both groups, but less frequently found in the LDLR−/−/MPO−/−tp group, although the difference was not statistically significant (0.75±0.31 vs. 0.50±0.27, p = 0.12). Hepatocyte ballooning, a feature of progressive human NASH, was not observed in either group. Plasma levels of ALT, a marker of hepatocyte injury, were lower in the LDLR−/−/MPO−/−tp mice (31.3±4.1 U/l vs. 43.2±3.8 U/l in LDLR−/−/MPO+/+tp mice, p<0.05).

thumbnail
Download:
Figure 3. Liver histology of LDLR−/−/MPO−/−tp animals in comparison with LDLR−/−/MPO+/+tp mice after 8 weeks of high-fat feeding.

Representative pictures of HE-stained liver sections of LDLR−/−/MPO−/−tp and LDLR−/−/MPO+/+tp mice indicating steatosis and inflammation (arrows).

https://doi.org/10.1371/journal.pone.0052411.g003

MPO Deficiency Leads to Reduced Liver Cholesterol but does not Affect Triglyceride Accumulation

Next, the effects of MPO deficiency on the development of hepatic steatosis were examined in more detail. Oil red O staining of liver sections did not reveal obvious differences with respect to distribution or extent of lipid accumulation between LDLR−/−/MPO+/+tp mice and LDLR−/−/MPO−/−tp mice (Fig. 4a). In line with this, biochemical analysis revealed similar liver triglyceride content in LDLR−/−/MPO−/−tp and LDLR−/−/MPO+/+tp animals (p = 0.24; Fig. 4b). Plasma triglyceride levels were also similar in LDLR−/−/MPO+/+tp and LDLR−/−/MPO−/tp- mice (Fig. 4c). In contrast, both plasma and hepatic cholesterol levels were significantly lower in LDLR−/−/MPO−/−tp mice after the high-fat diet as compared with the LDLR−/−/MPO+/+tp animals (33.5±1.2 vs. 39.5±1.9 mM; p = 0.01, and 0.072±0.005 vs. 0.090±0.004 µg/µg protein; p = 0.01, respectively; Fig. 4d,e), though cholesterol accumulation in the LDLR−/−/MPO−/−tp group was still higher compared to LDLR−/−/MPO+/+ animals on chow.

thumbnail
Download:
Figure 4. Decreased cholesterol accumulation in the liver of LDLR−/−/MPO−/−tp mice.

A) Representative Oil red O stainings of liver sections of LDLR−/−/MPO−/−tp and LDLR−/−/MPO+/+tp mice fed a high-fat diet for 8 weeks, showing comparable lipid accumulation (100× magnification). B) Similar hepatic triglyceride levels in LDLR−/−/MPO−/−tp and LDLR−/−/MPO+/+tp mice after high-fat feeding (0.31±0.02 vs. 0.35±0.02 µg/µg protein, p = 0.24). Chow-fed LDLR−/−/MPO+/+ mice show a lower level of liver triglycerides. C) Plasma triglyceride levels are similar in LDLR−/−/MPO−/−tp and LDLR−/−/MPO+/+tp animals after high-fat feeding (1.50±0.09 vs. 1.64±0.09 mmol/l, p = 0.42). D) High-fat feeding results in higher plasma cholesterol levels in LDLR−/−/MPO+/+tp animals as compared with LDLR−/−/MPO−/−tp mice (33.5±0.1 vs. 39.5±2.0 mmol/l, p = 0.02). E) Diet-induced liver cholesterol accumulation is reduced in LDLR−/−/MPO−/−tp mice compared with LDLR−/−/MPO+/+tp animals (0.072±0.004 vs. 0.090±0.004 µg/µg protein, p = 0.01), but does not reach the level observed in chow-fed LDLR−/−/MPO+/+ mice. F) Hepatic mRNA expression of key enzymes in cholesterol metabolism is not altered in LDLR−/−/MPO−/−tp mice, whereas scavenger receptor expression is reduced (SR-B1 1.7-fold, p<0.01; CD36 1.4-fold, p<0.01, SR-A 1.2-fold, p = 0.63).

https://doi.org/10.1371/journal.pone.0052411.g004

The differences in hepatic cholesterol do not appear to be due to altered synthesis, since hepatic gene expression of the two master regulators of cholesterol synthesis, SREBP1 and SREBF2, was comparable in both groups (p = 0.89, p = 0.32, respectively; Fig. 4f). Expression of hydroxymethylglutaryl-CoA reductase (HMGCR), the key rate-limiting enzyme in cholesterol synthesis, was also not significantly different (p = 0.42; Fig. 4f). Interestingly, however, expression of SR-A and CD36, two important proteins involved in the uptake of oxidized LDL, was lower in the LDLR−/−/MPO−/−tp group, although the difference was only significant for CD36 (p = 0.63, p<0.01, respectively; Fig. 4f). This may indicate reduced internalization of oxidized cholesterol in the liver of LDLR−/−/MPO−/−tp mice. Hepatic expression of SR-B1, a scavenger receptor mainly involved in the uptake of HDL-derived cholesterol and cholesteryl esters, was also decreased in LDLR−/−/MPO−/−tp mice (p<0.01, Fig. 4f).

Generalized Attenuation of High-fat Diet-induced Liver Inflammation in LDLR−/−/MPO−/−tp Mice

Active MPO has powerful pro-inflammatory effects, partly attributable to the generation of oxidized cholesterol [7], [24]. Therefore, we next investigated the effect of MPO deficiency on hepatic inflammation following high-fat feeding. The cellular nature of the inflammation was investigated by immunohistochemical analysis of Mac-1, Ly-6G, and CD3, markers of Kupffer cells/macrophages, neutrophils, and T-lymphocytes, respectively. Interestingly, the number of neutrophils and T-lymphocytes was significantly reduced in the liver of LDLR−/−/MPO−/−tp mice (p<0.05, p<0.05, respectively; Fig. 5a), and similar to the numbers observed in LDLR−/−/MPO+/+ mice on chow. Moreover, additional analyses of LDLR−/−/MPO−/−tp animals consistently revealed a strongly reduced expression of pro-inflammatory genes previously implicated in the pathogenesis of NASH (Fig. 5b). For example, tumor necrosis factor-α (TNF-α) and IL-1α mRNA expression were almost two-fold lower in the liver of LDLR−/−/MPO−/−tp mice compared with LDLR−/−/MPO+/+tp mice (p<0.05, p<0.01, respectively). In addition, hepatic IL-6 expression tended to be reduced in LDLR−/−/MPO−/−tp mice relative to LDLR−/−/MPO+/+tp mice, although the difference was not statistically significant. Hepatic monocyte chemoattractant protein-1 (Mcp-1) mRNA expression was over two-fold lower in LDLR−/−/MPO−/−tp mice (p<0.01), and, consistent with this, their CD68 mRNA expression was also significantly reduced. Taken together, these results show that MPO plays an important role in high-fat diet-induced inflammation of the liver, promoting both inflammatory cell recruitment and cytokine/chemokine expression.

thumbnail
Download:
Figure 5. General reduction of diet-induced hepatic inflammation in LDLR−/−/MPO−/−tp mice.

A) Significantly lower number of hepatic Ly-6G+ neutrophils and CD3+ T-lymphocytes in LDLR−/−/MPO−/−tp mice as compared with LDLR−/−/MPO+/+tp mice after 8 weeks of high-fat feeding (Ly-6G: 36.7±2.6 vs. 47.8±3.1 cells/mm2, p = 0.03; CD3: 49.1±4.2 vs. 62.9±5.0 cells/mm2, p = 0.04). Pictures represent examples of the stainings (200× magnification). B) Hepatic pro-inflammatory cytokine/chemokine expression is substantially reduced in LDLR−/−/MPO−/−tp mice after 8 weeks high-fat diet (TNF-α 1.8-fold, p = 0.03, IL-1α 1.6-fold, p<0.01, IL-6 1.3-fold, p = 0.67, Mcp-1 2.5-fold, p<0.01), in parallel with a reduction of CD68 expression (1.3-fold, p<0.05).

https://doi.org/10.1371/journal.pone.0052411.g005

Reduced High-fat Diet-induced Adipose Tissue Inflammation in LDLR−/−/MPO−/−tp Mice

The pathogenesis of NASH is mediated by cross-talk between inflamed adipose tissue and the liver [25]. In order to investigate the potential contribution of adipose tissue-derived factors to the reduced hepatic inflammation in LDLR−/−/MPO−/−tp mice, several inflammatory parameters were investigated. First of all, Ly-6G staining revealed an absence of neutrophils in visceral adipose tissue in both groups (data not shown). Next, visceral adipose tissue was stained for the macrophage marker F4/80. High-fat diet-induced obesity is characterized by infiltration of macrophages into adipose tissue, where they organize into so-called ‘crown-like structures’ surrounding dead adipocytes [21]. Interestingly, adipose tissue of LDLR−/−/MPO−/−tp mice was completely devoid of such crown-like structures, whereas they were readily identifiable in adipose tissue of LDLR−/−/MPO+/+tp mice (Fig. 6a). Quantitative PCR analysis of adipose tissue Mac-1 expression, another macrophage marker, was in line with these results, showing a marked reduction in LDLR−/−/MPO−/−tp animals (p<0.05; Fig. 6b). Similarly, expression of Mcp-1, a potent chemo-attractant for monocytes, was strongly reduced in the LDLR−/−/MPO−/−tp group (p<0.05; Fig. 6b). Furthermore, adipose tissue expression of the pro-inflammatory adipokines leptin and TNF-α was lower in LDLR−/−/MPO−/−tp animals, whereas expression of adiponectin, which has anti-inflammatory properties, was higher (Fig. 6c). Thus, MPO deficiency protects adipose tissue from high-fat diet-induced inflammation, which may contribute to the attenuation of inflammation in the liver of LDLR−/−/MPO−/−tp mice.

thumbnail
Download:
Figure 6. Reduced diet-induced adipose tissue inflammation in LDLR−/−/MPO−/−tp mice.

A) Lack of high-fat diet-associated macrophage ‘crown-like structures’ in visceral adipose tissue of LDLR−/−/MPO−/−tp mice as revealed by F4/80 immunostaining (200× magnification). B) Adipose tissue mRNA expression of the macrophage marker Mac-1 and the macrophage chemokine Mcp-1 is significantly lower in LDLR−/−/MPO−/−tp mice fed a high-fat diet for 8 weeks (p<0.05). C) Reduced adipose tissue expression of the adipokines leptin and TNF-α in LDLR−/−/MPO−/−tp mice after 8 weeks of high-fat feeding, whereas expression of adiponectin is increased.

https://doi.org/10.1371/journal.pone.0052411.g006

Decreased Liver Fibrosis in LDLR−/−/MPO−/−tp Mice

Progression of NAFLD, mediated by sustained inflammation, ultimately results in the development of hepatic fibrosis. Since MPO exerts strong effects on various mechanisms involved in fibrogenesis and has been implicated in pro-fibrotic states in various other chronic inflammatory conditions, we next evaluated parameters of fibrosis in the liver of LDLR−/−/MPO−/−tp and LDLR−/−/MPO+/+tp mice. As expected in this dietary model of NASH, Sirius red staining of collagen in liver sections indicated only mild fibrosis in both groups (Fig. 7a). However, collagen content appeared to be slightly decreased in LDLR−/−/MPO−/−tp as compared to LDLR−/−/MPO+/+tp mice. More detailed quantitative biochemical analysis of the collagen/elastin content in liver homogenates as determined by hydroxyproline quantity revealed a lower amount in LDLR−/−/MPO−/−tp mice (p<0.01), supporting that their liver was less fibrotic (Fig. 7b). This was further substantiated by the fact that hepatic gene expression of collagen 1A1 was lower in the LDLR−/−/MPO−/−tp group (p<0.05; Fig. 7c). Moreover, mRNA levels of PAI-1, an important regulator of hepatic fibrosis, were significantly reduced in these animals (p<0.01; Fig. 7c). Expression of other fibrosis-related parameters such as tissue inhibitor of metalloproteinase 1 (TIMP1), α-smooth muscle actin (α-SMA), MMP-13, TGF-β1, and BAMBI was also reduced although not to a statistically significant extent (p = 0.15, p = 0.19, p = 0.12, p = 0.06, p = 0.39, respectively); Fig. 7c). Overall, these data suggest that MPO may promote the progression of NAFLD towards more advanced stages with fibrosis.

thumbnail
Download:
Figure 7. Attenuation of liver fibrosis in LDLR−/−/MPO−/−tp mice after 8 weeks high-fat diet.

A) Sirius red staining of liver sections of LDLR−/−/MPO−/−tp,LDLR−/−/MPO+/+tp, and chow-fed LDLR−/−/MPO+/+ mice (200× magnification). B) The amount of hydroxyproline, a protein modification specifically present in collagen and elastin, is significantly lower in the liver of LDLR−/−/MPO−/−tp mice in comparison with LDLR−/−/MPO+/+tp mice (3.3±0.2 vs. 4.6±0.7 nmol/mg tissue, p<0.01). C) LDLR−/−/MPO−/−tp mice display reduced expression of collagen type I, PAI-1, TIMP1, α-SMA, MMP-13, TGF-β1, and BAMBI, genes associated with hepatic fibrosis.

https://doi.org/10.1371/journal.pone.0052411.g007

Discussion

Hepatic inflammation is one of the defining criteria in the diagnosis of NASH, and primarily characterized by the abundant presence of neutrophils [26]. Neutrophils are equipped with formidable enzyme systems that generate factors with a high potential of causing tissue damage, most prominently represented by MPO. The results of the present study point to an important role for MPO in the development of NASH by increasing hepatic cholesterol accumulation, inflammation, and fibrosis.

The effect of MPO deficiency on plasma lipid levels and inflammation was previously studied in the context of atherosclerosis [20], [27]. In line with our findings, plasma triglyceride levels were comparable between LDLR−/−/MPO−/− and LDLR−/−/MPO+/+ mice, whereas plasma cholesterol was lower in mice lacking MPO. We now report that hepatic cholesterol levels are also reduced in LDLR−/−/MPO−/−tp mice after high-fat feeding. There are several mechanisms by which MPO might affect plasma and liver cholesterol levels. MPO is known to inhibit cholesterol efflux from lipid-laden macrophages by oxidizing apoA-I in HDL [28]. MPO is also able to oxidize other apolipoproteins including apoB, an important component of LDL [29]. This may alter interaction with hepatocyte receptors and contribute to dyslipidemia by affecting clearance. Furthermore, nitrotyrosine formation on apoB-100 leads to enhanced uptake of cholesterol-containing LDL by macrophages [30]. Identification of the relative importance of these mechanisms for the observed reduction of total liver and plasma cholesterol levels will require detailed analysis of lipoprotein profiles. In view of mounting evidence that Kupffer cells acquire characteristics similar to lipid-laden macrophages/foam cells in response to high-fat feeding [2], [12], reduced hepatic cholesterol in LDLR−/−/MPO−/−tp mice may be related to diminished formation of foamy Kupffer cells.

Regardless of the mechanism, the reduced cholesterol levels in LDLR−/−/MPO−/−tp animals are significant in light of recent data indicating that cholesterol plays a pivotal role in the induction of inflammation in NASH [12], [31]. In this context, scavenging of oxidized cholesterol/lipoprotein particles by Kupffer cells and hepatocytes may be an initiating factor. Uptake of oxidized LDL/HDL is mediated by scavenger receptors, and is associated with chronic inflammation [32]. Of note, scavenger receptor expression is regulated by oxidized LDL through a positive feedback loop [33]. The reduced expression of CD36 that we found in the liver of LDLR−/−/MPO−/−tp mice may therefore be indicative of lower oxidized LDL levels, consistent with lower MPO activity. Future studies on the levels of oxidized cholesterol in plasma and liver are required to further define the mechanisms involved.

In addition to the pro-inflammatory effects related to cholesterol accumulation and modification, MPO can promote inflammation in various other ways. Firstly, MPO-mediated generation of HOCl and NO2 radicals directly results in chlorination and nitration of proteins and nucleic acids [7] reflecting cellular damage, a potent inducer of inflammation. The fact that hepatic nitrotyrosine levels were lower in LDLR−/−/MPO−/−tp mice suggests that MPO-mediated protein nitration may indeed contribute to high-fat diet-induced hepatic inflammation. Secondly, MPO and MPO-derived HOCl activate NF-κB signalling and increase TNF-α production by macrophages and other leukocytes [9], [10], [34]. This is consistent with our observation of lower hepatic and adipose tissue TNF-α expression in the LDLR−/−/MPO−/−tp mice, and may be related to an interaction between neutrophil-derived MPO and hepatic macrophages. Importantly, pro-inflammatory TNF-α and NF-κB signalling are key factors in the progression of NAFLD [1]. Thirdly, MPO activity is linked to lipid peroxidation, which is a prominent characteristic of fatty livers, promoting activation of stellate cells and attraction of inflammatory cells [35], [36]. Indeed, the substantial reduction of hepatic neutrophils and T-lymphocytes in LDLR−/−/MPO−/−tp mice provides supporting evidence for an important role of MPO-mediated lipid peroxidation in chemo-attraction of leukocytes in NASH.

Interestingly, we observed reduced numbers of adipose tissue macrophages in LDLR−/−/MPO−/−tp mice. This is in line with recent data indicating that high-fat diet-induced infiltration of macrophages into adipose tissue is preceded by neutrophil infiltration [37]. Moreover, lipid peroxidation is known to be markedly elevated in adipose tissue of obese mice [38]. Hence, our findings suggest that the reported early diet-induced sequestration of neutrophils in adipose tissue may promote lipid peroxidation via MPO-dependent mechanisms. Furthermore, accumulation of oxidized lipids in adipose tissue is associated with dysregulated adipokine expression [38], which is in line with our data on leptin and adiponectin expression. Importantly, reduced adiponectin and increased leptin secretion by adipose tissue promotes lipid accumulation, inflammation, and fibrogenesis in the liver [39].

Next to dysregulated adiponectin and leptin expression, numerous other factors modulated by MPO and MPO-derived products affect the development of fibrosis. For example, MPO-generated oxidants activate matrix metalloproteinases [40] while inhibiting protease inhibitors such as TIMP1 [41]. These actions are thought to suppress fibrosis. In contrast, high levels of MPO-derived HOCl can also inactivate matrix metalloproteinase 7 [42], thereby promoting fibrosis. Furthermore, MPO-related lipid peroxidation products stimulate stellate cell synthesis of type I collagen, the major collagen of the fibrotic liver [43], which expression was significantly reduced in the LDLR−/−/MPO−/−tp mice. Finally, HOCl fragments the extracellular matrix [11], which is associated with stellate cell activation as well. Our data indicate that in vivo, the pro-fibrotic effects of MPO may outweigh anti-fibrotic processes in the context of NASH, even though the fibrosis we observed was still very mild.

Our findings are likely to be clinically important since human NAFLD is associated with high numbers of MPO-expressing cells and accumulation of HOCl-modified and nitrated proteins [4], [5], [8]. Furthermore, there is strong evidence for increased oxidative stress and extensive lipid peroxidation in human NASH [4], [36], [44]. In this regard it is also important to note that in comparison to the mouse, human blood contains 5–7 times more neutrophils with a longer half-life, each containing about 10-fold more MPO [6], [45]. As such, it is likely that the contribution of MPO to the progression of NAFLD in man is more pronounced. Moreover, high and sustained MPO activity results in oxidative DNA damage [46], which is associated with the ultimate and most devastating complication of NASH, hepatocellular carcinoma [36].

In conclusion, we have shown that MPO-deficiency diminishes high-fat diet-induced NASH by reducing hepatic cholesterol accumulation, inflammation, and fibrosis. Furthermore, our data indicate a general role for MPO in the chronic inflammation associated with obesity and insulin resistance, and therefore argue for a re-evaluation of the role of neutrophils and their cytotoxic products in the pathogenesis of metabolic disease.

Acknowledgments

We would like to thank Dr. Ellen Loyens and Dr. Kristiaan Wouters for their valuable contribution to the study, Dr. Marion Gijbels for evaluation of liver histology, and Dr. Petra Niessen, Patrick van Gorp, and Dr. Marcella van Leeuwen for excellent technical support. The critical review of the manuscript by Dr. E. Malle is greatly appreciated.

Author Contributions

Conceived and designed the experiments: SR WB JWG RS. Performed the experiments: SR VB SX EA JB. Analyzed the data: SR VB SX EA JB WB. Contributed reagents/materials/analysis tools: MH RS WB. Wrote the paper: SR VB SX RS MH JWG WB.

References

  1. 1. Marra F, Gastaldelli A, Svegliati Baroni G, Tell G, Tiribelli C (2008) Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol Med 14: 72–81.
  2. 2. Baffy G (2009) Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J Hepatol 51: 212–223.
  3. 3. Rensen SS, Slaats Y, Driessen A, Peutz-Kootstra CJ, Nijhuis J, et al. (2009) Activation of the complement system in human nonalcoholic fatty liver disease. Hepatology 50: 1809–1817.
  4. 4. Ikura Y, Ohsawa M, Suekane T, Fukushima H, Itabe H, et al. (2006) Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: impact on disease progression. Hepatology 43: 506–514.
  5. 5. Rensen SS, Slaats Y, Nijhuis J, Jans A, Bieghs V, et al. (2009) Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis. Am J Pathol 175: 1473–1482.
  6. 6. Klebanoff SJ (2005) Myeloperoxidase: friend and foe. J Leukoc Biol 77: 598–625.
  7. 7. Malle E, Furtmuller PG, Sattler W, Obinger C (2007) Myeloperoxidase: a target for new drug development? Br J Pharmacol 152: 838–854.
  8. 8. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, et al. (2001) Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120: 1183–1192.
  9. 9. Lefkowitz DL, Mills KC, Moguilevsky N, Bollen A, Vaz A, et al. (1993) Regulation of macrophage function by human recombinant myeloperoxidase. Immunol Lett 36: 43–49.
  10. 10. Lau D, Mollnau H, Eiserich JP, Freeman BA, Daiber A, et al. (2005) Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. Proc Natl Acad Sci U S A 102: 431–436.
  11. 11. Woods AA, Davies MJ (2003) Fragmentation of extracellular matrix by hypochlorous acid. Biochem J 376: 219–227.
  12. 12. Wouters K, van Gorp PJ, Bieghs V, Gijbels MJ, Duimel H, et al. (2008) Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 48: 474–486.
  13. 13. Aratani Y, Koyama H, Nyui S, Suzuki K, Kura F, et al. (1999) Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect Immun 67: 1828–1836.
  14. 14. Bieghs V, Wouters K, van Gorp PJ, Gijbels MJ, de Winther MP, et al. (2010) Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice. Gastroenterology 138: 2477–2486.
  15. 15. Bieghs V, Van Gorp PJ, Wouters K, Hendrikx T, Gijbels MJ, et al. (2012) LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease. PLoS One 7: e30668.
  16. 16. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497–509.
  17. 17. Waterval WA, Scheijen JL, Ortmans-Ploemen MM, Habets-van der Poel CD, Bierau J (2009) Quantitative UPLC-MS/MS analysis of underivatised amino acids in body fluids is a reliable tool for the diagnosis and follow-up of patients with inborn errors of metabolism. Clin Chim Acta 407: 36–42.
  18. 18. Gupte AA, Liu JZ, Ren Y, Minze LJ, Wiles JR, et al. (2010) Rosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice. Hepatology 52: 2001–2011.
  19. 19. Collins AR, Lyon CJ, Xia X, Liu JZ, Tangirala RK, et al. (2009) Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes. Circ Res 104: e42–54.
  20. 20. van Leeuwen M, Gijbels MJ, Duijvestijn A, Smook M, van de Gaar MJ, et al. (2008) Accumulation of myeloperoxidase-positive neutrophils in atherosclerotic lesions in LDLR−/− mice. Arterioscler Thromb Vasc Biol 28: 84–89.
  21. 21. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, et al. (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 46: 2347–2355.
  22. 22. van der Veen BS, de Winther MP, Heeringa P (2009) Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease. Antioxid Redox Signal 11: 2899–2937.
  23. 23. Gaut JP, Byun J, Tran HD, Lauber WM, Carroll JA, et al. (2002) Myeloperoxidase produces nitrating oxidants in vivo. J Clin Invest 109: 1311–1319.
  24. 24. Hamilton TA, Major JA, Chisolm GM (1995) The effects of oxidized low density lipoproteins on inducible mouse macrophage gene expression are gene and stimulus dependent. J Clin Invest 95: 2020–2027.
  25. 25. Tilg H, Hotamisligil GS (2006) Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance. Gastroenterology 131: 934–945.
  26. 26. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94: 2467–2474.
  27. 27. Brennan ML, Anderson MM, Shih DM, Qu XD, Wang X, et al. (2001) Increased atherosclerosis in myeloperoxidase-deficient mice. J Clin Invest 107: 419–430.
  28. 28. Zheng L, Nukuna B, Brennan ML, Sun M, Goormastic M, et al. (2004) Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest 114: 529–541.
  29. 29. Hazell LJ, Arnold L, Flowers D, Waeg G, Malle E, et al. (1996) Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest 97: 1535–1544.
  30. 30. Podrez EA, Schmitt D, Hoff HF, Hazen SL (1999) Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J Clin Invest 103: 1547–1560.
  31. 31. Mari M, Caballero F, Colell A, Morales A, Caballeria J, et al. (2006) Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. Cell Metab 4: 185–198.
  32. 32. Moore KJ, Freeman MW (2006) Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol 26: 1702–1711.
  33. 33. Hofnagel O, Luechtenborg B, Weissen-Plenz G, Robenek H (2007) Statins and foam cell formation: impact on LDL oxidation and uptake of oxidized lipoproteins via scavenger receptors. Biochim Biophys Acta 1771: 1117–1124.
  34. 34. Schoonbroodt S, Legrand-Poels S, Best-Belpomme M, Piette J (1997) Activation of the NF-kappaB transcription factor in a T-lymphocytic cell line by hypochlorous acid. Biochem J 321 (Pt 3): 777–785.
  35. 35. Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, et al. (2000) CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 105: 1067–1075.
  36. 36. Seki S, Kitada T, Yamada T, Sakaguchi H, Nakatani K, et al. (2002) In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol 37: 56–62.
  37. 37. Elgazar-Carmon V, Rudich A, Hadad N, Levy R (2008) Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding. J Lipid Res 49: 1894–1903.
  38. 38. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, et al. (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114: 1752–1761.
  39. 39. Tsochatzis E, Papatheodoridis GV, Archimandritis AJ (2006) The evolving role of leptin and adiponectin in chronic liver diseases. Am J Gastroenterol 101: 2629–2640.
  40. 40. Ra HJ, Parks WC (2007) Control of matrix metalloproteinase catalytic activity. Matrix Biol 26: 587–596.
  41. 41. Wang Y, Rosen H, Madtes DK, Shao B, Martin TR, et al. (2007) Myeloperoxidase inactivates TIMP-1 by oxidizing its N-terminal cysteine residue: an oxidative mechanism for regulating proteolysis during inflammation. J Biol Chem 282: 31826–31834.
  42. 42. Fu X, Kassim SY, Parks WC, Heinecke JW (2003) Hypochlorous acid generated by myeloperoxidase modifies adjacent tryptophan and glycine residues in the catalytic domain of matrix metalloproteinase-7 (matrilysin): an oxidative mechanism for restraining proteolytic activity during inflammation. J Biol Chem 278: 28403–28409.
  43. 43. Lee KS, Buck M, Houglum K, Chojkier M (1995) Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest 96: 2461–2468.
  44. 44. Videla LA, Rodrigo R, Araya J, Poniachik J (2006) Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease. Trends Mol Med 12: 555–558.
  45. 45. Boxio R, Bossenmeyer-Pourie C, Steinckwich N, Dournon C, Nusse O (2004) Mouse bone marrow contains large numbers of functionally competent neutrophils. J Leukoc Biol 75: 604–611.
  46. 46. Shen Z, Wu W, Hazen SL (2000) Activated leukocytes oxidatively damage DNA, RNA, and the nucleotide pool through halide-dependent formation of hydroxyl radical. Biochemistry 39: 5474–5482.